X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (9) 9
double-blind method (7) 7
humans (7) 7
female (5) 5
male (5) 5
benzoxazoles - therapeutic use (4) 4
cardiomyopathy (4) 4
transthyretin (4) 4
amyloid neuropathies, familial - drug therapy (3) 3
amyloidosis (3) 3
antipsychotic agents - therapeutic use (3) 3
disease progression (3) 3
double-blind (3) 3
drug therapy (3) 3
heart diseases (3) 3
heart failure (3) 3
medicine, general & internal (3) 3
medicine, research & experimental (3) 3
middle aged (3) 3
mortality (3) 3
mutation (3) 3
original (3) 3
patient safety (3) 3
patients (3) 3
piperazines - therapeutic use (3) 3
polyneuropathy (3) 3
psychiatry (3) 3
research (3) 3
thiazoles - therapeutic use (3) 3
treatment outcome (3) 3
ziprasidone (3) 3
administration, oral (2) 2
adolescent (2) 2
adult (2) 2
aged (2) 2
analysis (2) 2
antipsychotic agents - adverse effects (2) 2
biochemistry & molecular biology (2) 2
bipolar disorder (2) 2
bipolar disorder - drug therapy (2) 2
cardiac & cardiovascular systems (2) 2
cardiac amyloidosis (2) 2
cardiomyopathies - drug therapy (2) 2
care and treatment (2) 2
clinical trials (2) 2
dosage and administration (2) 2
effectiveness (2) 2
efficacy (2) 2
heart-failure (2) 2
hereditary amyloidosis (2) 2
medical prognosis (2) 2
medicine (2) 2
mutations (2) 2
neuropathy (2) 2
original articles (2) 2
patient outcomes (2) 2
pediatrics (2) 2
pharmacology & pharmacy (2) 2
piperazines - adverse effects (2) 2
polyneuropathies (2) 2
poster presentation (2) 2
prospective studies (2) 2
rating-scale (2) 2
safety (2) 2
schizoaffective disorder (2) 2
schizophrenia (2) 2
secondary prevention (2) 2
studies (2) 2
survival analysis (2) 2
tafamidis (2) 2
thiazoles - adverse effects (2) 2
transplantation (2) 2
6-week (1) 1
abridged index medicus (1) 1
acute bipolar mania (1) 1
acute exacerbation (1) 1
acute mania (1) 1
administration, oral; aged; aged, 80 and over; amyloid neuropathies, familial; benzoxazoles; cardiomyopathies; disease progression; double-blind method; female; heart failure; hospitalization; humans; male; middle aged; prealbumin; quality of life; survival analysis; walk test; medicine (1) 1
african-americans (1) 1
age (1) 1
aged, 80 and over (1) 1
amyloid (1) 1
amyloid neuropathies - drug therapy (1) 1
amyloid neuropathies - metabolism (1) 1
amyloid neuropathies - physiopathology (1) 1
amyloid neuropathies, familial - complications (1) 1
amyloid neuropathies, familial - diagnosis (1) 1
amyloid neuropathies, familial - physiopathology (1) 1
amyloidogenesis (1) 1
amyloidosis - drug therapy (1) 1
amyloidosis - metabolism (1) 1
anti-inflammatory agents, non-steroidal - therapeutic use (1) 1
antipsychotics (1) 1
article (1) 1
attr (1) 1
attrv30m (1) 1
authorship (1) 1
baseline severity (1) 1
benzoxazoles - adverse effects (1) 1
binding sites (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 09/2018, Volume 379, Issue 11, pp. 1007 - 1016
Journal Article
Clinical Medicine Insights: Cardiology, ISSN 1179-5468, 09/2017, Volume 2017, Issue 11, pp. 1179546817730322 - 1179546817730322
Background: Transthyretin cardiomyopathy (TTR-CM) is a progressive, fatal disease caused by the accumulation of misfolded transthyretin (TTR) amyloid fibrils... 
cardiac amyloidosis | heart failure | tafamidis | Transthyretin | Studies | Heart failure | Survival analysis | Authorship | Cardiomyopathy | Medical prognosis | Mortality | Classification | Peer review | Patients | Age
Journal Article
Journal of Cardiac Failure, ISSN 1071-9164, 08/2019, Volume 25, Issue 8, pp. S7 - S7
In the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT), tafamidis reduced all-cause mortality and cardiovascular-related hospitalizations... 
Medical research | Cardiomyopathy | Mortality | Medicine, Experimental | Clinical trials | Medical law | Heart diseases
Journal Article
Amyloid, ISSN 1350-6129, 01/2017, Volume 24, Issue 1, pp. 30 - 36
Background: Tafamidis, a non-NSAID highly specific transthyretin stabilizer, delayed neurologic disease progression as measured by Neuropathy Impairment... 
familial amyloid neuropathy | Amyloidosis | disease-modifying drug | tafamidis | transthyretin | polyneuropathy | MEDICINE, RESEARCH & EXPERIMENTAL | MEDICINE, GENERAL & INTERNAL | HEREDITARY AMYLOIDOSIS | BIOCHEMISTRY & MOLECULAR BIOLOGY | MUTATIONS | TRANSPLANTATION | Index Medicus
Journal Article
Amyloid, ISSN 1350-6129, 07/2019, pp. 1 - 7
Background: Tafamidis is approved in over 40 countries to delay neurologic progression in patients with transthyretin amyloid polyneuropathy (ATTR-PN). A... 
Index Medicus
Journal Article
Orphanet Journal of Rare Diseases, ISSN 1750-1172, 2015, Volume 10, Issue Suppl 1, p. P12
Journal Article
Journal of Cardiac Failure, ISSN 1071-9164, 11/2018, Volume 24, Issue 11, pp. 813 - 813
Transthyretin cardiomyopathy (ATTR-CM) is an underdiagnosed, fatal disease caused by the deposition of transthyretin amyloid fibrils in the heart leading to... 
CARDIAC & CARDIOVASCULAR SYSTEMS | Cardiomyopathy | Heart diseases | Analysis
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.